Calidi Biotherapeutics Inc. (CLDI) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Calidi Biotherapeutics In...

    AMEX: CLDI · Real-Time Price · USD
    1.61
    -0.10 (-5.85%)
    At close: Aug 29, 2025, 3:59 PM
    1.64
    1.98%
    After-hours: Aug 29, 2025, 07:56 PM EDT

    Calidi Biotherapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021
    Period Ending Jun 30, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021
    Net Income
    		 -7.22M -8.23M -2.02M -4.27M -2.22M -2.59M 493.57K 4.16M 1.46M 4.29M -823.29K
    Depreciation & Amortization
    		 374K 364K 100K 364K 183K 91K 68K n/a n/a n/a n/a
    Stock-Based Compensation
    		 888K 1.19M 1.11M 1.08M 1.43M 1.06M 1.06M n/a n/a n/a n/a
    Other Working Capital
    		 949K 9.16M -12.55M 1.46M 1.86M 2.54M 574.69K 92.94K 63.73K 1.05M -1.36M
    Other Non-Cash Items
    		 883K 419K -7.69M 3.19M 555.7K 1.22M -1.4M -4.52M -1.99M -4.9M 718.08K
    Deferred Income Tax
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Change in Working Capital
    		 1.92M 2.99M -12.55M 1.46M 1.86M 2.53M 574.69K 92.94K 63.73K 1.11M -1.36M
    Operating Cash Flow
    		 -3.83M -5.19M -22.37M 381.5K 192.29K 1.17M -333.27K -268.68K -465.13K 505.44K -1.47M
    Capital Expenditures
    		 -5K -70K -515K -306K -137K -161K -67K n/a n/a n/a n/a
    Cash Acquisitions
    		 n/a n/a 9K n/a n/a n/a n/a n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a 1.34M -916.75K -425.85K -2.32M n/a n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a -622.29K 622.29K n/a 190.01M n/a n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a 35K 72K 63K n/a -189.59M 189.59M n/a n/a n/a n/a
    Investing Cash Flow
    		 -5K -35K 277.31K -294.46K -425.85K -1.91M 189.59M n/a n/a n/a -230M
    Debt Repayment
    		 3.18M -2.3M 978.5K 500K 222.5K 797.5K -8K n/a n/a -935K -188.8K
    Common Stock Repurchased
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Financial Acitivies
    		 -164K -660K -9.64M 6.08M n/a 3.52M 468K 2.78M 732K 2.43M -2.34M
    Financial Cash Flow
    		 3.01M -2.96M 31.28M 500K 222.5K 797.5K -189.55M n/a n/a -640.13K 232.57M
    Net Cash Flow
    		 -806K -8.2M 9.58M 587.04K -11.06K 53.95K -288.9K -268.68K -465.13K -134.69K 1.1M
    Free Cash Flow
    		 -3.84M -5.26M -22.89M 75.5K 55.29K 1M -400.27K -268.68K -465.13K 505.44K -1.47M

    Add to Watchlist